BOXPARK was founded in 2011 by Roger Wade and has evolved from being the world’s first pop-up mall to one of London’s most high-profile branded dining, leisure and retail developments.

LDC backed the business in 2021 to support the management team’s national expansion plans to launch new sites in London and in major regional cities.

Expansion across the UK

In addition to its existing London locations,  BOXPARK launched its first development outside of the capital in Liverpool in 2024.

Headquartered in Nottingham, Addo Food Group (Addo) is the UK’s leading chilled savoury pastry producer, producing more than 297 million products each year.

The business manufactures a range of own brand and branded products including sausage rolls, hot pies, slices, pork pies, scotch egg products and quiches, which it supplies to the UK’s leading names in food retail including all the major supermarkets.

Headland is a London-based agency specialising in financial and corporate reputation, public affairs and campaigning.

Today the company employs 117 people and its clients include Accenture, ASOS, Danone, eBay, Future, Just Eat Takeaway.com, PepsiCo, Pret, Saga, Three UK, TikTok, UBS, Versus Arthritis and Watches of Switzerland.

We supported the international growth strategy of Kee Safety over ten years, reinvesting multiple times to continue our backing of leader Chris Milburn. We first invested in Kee Safety in 2011 and in 2017, backed the business for a third time following the acquisition of Kee Safety by Investcorp, a deal named ‘International Deal of the Year’ at the Midlands Dealmaker Awards, before exiting fully in 2021.

Headquartered in Birmingham, Kee Safety is the leading provider of fall protection products and solutions associated with working at height. With a longstanding reputation for quality, reliability and safety, its expertise spans fall prevention, roof edge protection, barrier and guardrail systems and safe access solutions.

Chief Executive Chris Milburn chose to partner with LDC in 2011, looking to us to help fund an ambitious growth strategy which included product innovation, optimising and expanding routes to market, driving international expansion and augmenting organic growth with complementary acquisitions.

Commitment to long-term growth

Since the start, LDC has supported the significant growth of the business both at home and overseas, both organically and via acquisition with 11 complementary acquisitions over a period of four years.

We completed the sale of our first stake in Kee Safety in 2013 in a £90m deal with Dunedin. As part of that deal, we re-invested to further support the business’s fast growth strategy.

In 2017 the business was acquired by Investcorp and we backed it for a third time in a £280m deal that would see us continue to lend both financial support and expertise to the management team.

Lucid Group is an industry-leading healthcare communications specialist. In its aim to drive better disease and patient management, Lucid provides medical education, medical communication, strategic consultancy and digital services to its clients.

Founded in 2007 by Jan Steele and Dennis O’Brien, the group comprises of five ‘family members’: Bluedog, Leading Edge, Lighthouse, Lucid Partners and ViVid.

Minority investment to support growth

Lucid Group secured an £11m minority investment from LDC in June 2017, to support continued organic sales growth, expansion of the service offering including into digital and creative and further development of Lucid’s presence in the US.

Founded in 1995, Sohonet provides media companies with a wide range of technically advanced and highly secure solutions to support each stage of the production workflow.

The business has a global presence including locations in London, Los Angeles, New York and Sydney.

LDC invested in Sohonet in March 2021 to help the management team build on its international growth strategy and explore complementary acquisitions.

In 2023, Sohonet acquired Los Angeles-based 5th Kind, a leading cloud-based media software platform for the film and TV production industry.

ChargePoint manufactures and delivers enhanced sterile & contained process solutions to companies across Europe, Asia and North America.

Its patented technology is used by the world’s top 50 global pharmaceutical manufacturers. It helps transfer highly potent and sterile powders reliably and safely within advanced manufacturing facilities.

Turning on the growth tap

LDC first backed ChargePoint CEO Chris Eccles in 2017, providing investment to help the business to capitalise on growing international demand for its products.

The partnership also gave Chris the financial firepower to increase investment in new product development, allowing ChargePoint to expand its market share by manufacturing complementary, single use products alongside continuing improvement of its core range.

Texthelp has supported 30 million students and employees with reading, writing and numeracy as well as productivity challenges, including those with dyslexia or working in a second language. Its products include literacy support software Read&Write, maths product EquatIO, web accessibility toolbar Browsealoud and recently launched writing achievement tool WriQ.

The firm employs more than 180 staff across its headquarters in Belfast and international offices.

Texthelp has an established and loyal customer base across the Americas, Europe, Middle East and Australasia, including some of the largest school districts in North America and Australia, as well as Fortune 500 organisations.

The company partners with the world’s leading technology brands including Google, Microsoft and Apple to deliver solutions that work across all major mobile, tablet and computer operating systems.

An investment in growth

LDC backed the business in May 2019, supporting the management team to accelerate its organic growth plans, in the UK, US and internationally and further develop its software proposition.

Texthelp enhanced its market leading position by expanding its footprint across North America, developing its digital route to market and pricing strategies, and significantly investing in new technology and product development. This has included the recent launch of WriQ, a cloud-based writing assessment, benchmarking and achievement tool that allows teachers to automatically assess writing proficiency, provide students with specific and personalised feedback and track student performance over time.

Agentis Health Group (previously Ashtons) is a UK-based digital health specialist focused on transforming long-term condition management through the integration of medicines management, diagnostics and digital therapeutics. The Group comprises three core service areas: Agentis Healthcare, Agentis Therapeutics and Agentis Diagnostics.

A single, scalable platform

Founded on Ashtons, a leading medicines management, training and prescribing technology provider established in 1984, Agentis Health Group brings together a unique blend of expertise across clinical and digital excellence, therapeutics and healthcare management, medicines management and diagnostics to provide a single, scalable platform designed to help the NHS deliver smarter, more joined-up care.

In March 2020, LDC backed Ashtons to support its growth strategy, develop its infrastructure and distribution network, and enhance its technology platform.

In December 2021, the business acquired Firza, an experienced provider of clinical pharmacy services to support primary care providers in the UK.

Strategic relationships

In July 2024, Ashtons announced a new five-year contract with Priory, the UK’s largest independent provider of mental health services, for its new e-Works electronic prescribing and medicines management solution, continuing its longstanding partnership.

In September 2025, Agentis Health Group launched with the acquisition of Living With, a leading digital health company specialising in condition-specific therapeutics and remote patient assessment, management and rehabilitation.

Headquartered in London, Babble provides a wide range of unified communications and cyber security solutions for over 2,000 small and mid-sized businesses.

Formerly known as IP Solutions, the company’s services include hosted telephony (VOIP), unified communications, cloud contact centres, mobile and enterprise connectivity.

In 2017, the management team secured investment from LDC to accelerate their growth strategy through acquisitions and to support organic growth through new product innovations.

ADEY specialises in the design, manufacture, and supply of innovative products and services that significantly improve the effectiveness of domestic and commercial heating and cooling systems and water treatment systems.

Royal recognition

LDC invested in ADEY in June 2016, backing the business to expand internationally.

ADEY has been awarded the Queen’s Award for Enterprise in International Trade three times. The award recognises ADEY’s homegrown success and expansion into 19 European countries as well as China, the United States, Australia and New Zealand.

In 2019, ADEY also ranked 111th in The Sunday Times International Track 200 after recording £4.1m sales to the EU in 2017, an increase of over 55 per cent on the previous year.

Backing domestic expansion

With LDC’s support, ADEY invested heavily in product development and, in an industry first, launched a next generation universal water testing kit which provides lab-style reporting and interpretation instantly to a smartphone.

The business also strengthened its commercial water-testing service through its acquisition of Alpha Scientific in 2019 and added additional sites including a new satellite lab in Manchester. ADEY also opened a new purpose-built, 44,000 sq ft manufacturing and distribution facility in Gloucestershire.

During a four-and-a-half-year partnership, the business has grown net revenues from £34m (FY15) to £51m for the year ending 31 December 2020.

Biozone Scientific was founded in 1996 with a focus on using natural, chemical-free UV solutions for air purification.

The company’s global HQ is in the UK, with sales and operations located in Orlando Florida, Hong Kong, Shenzhen China, Toronto Canada, and the UK. Biozone Scientific also partners with distributor and manufacturing specialists all around the globe to expand the business reach.

Future global strategy

With LDC’s backing, the business plans to accelerate sales in the US, open new in-country offices in other key territories and invest in the development of next-generation products.